Brief: From concept to demonstration, this video highlights the evolution and practical outcomes of non-toxic, non-immunogenic stem cell-derived exosomes in liquid storage for safe therapy. You'll see how this innovative treatment is applied for cartilage repair in conditions like rhinitis and osteoarthritis, exploring its clinical benefits and mechanisms of action.
Related Product Features:
Derived from human cells with high biocompatibility to minimize immune rejection and side effects.
Contains active substances like protein, mRNA, miRNA, and growth factors to stimulate chondrocyte proliferation.
Features precise targeting via surface molecules that bind accurately to chondrocyte receptors for targeted delivery.
Regulates inflammation by inhibiting pro-inflammatory factors and promoting anti-inflammatory factors.
Stimulates collagen and proteoglycan secretion to enhance cartilage elasticity and repair damaged matrix.
Stored in liquid form at 2°C-8°C, ensuring stability and purity of at least 95%.
Applicable for various cartilage injuries, including degenerative and traumatic arthritis in joints.
Supports cartilage structure restoration and function improvement through extracellular matrix synthesis.
Sorular:
What is the source and purity of the exosomes?
The exosomes are derived from human cells and have a purity of at least 95%, ensuring high quality and effectiveness for therapeutic use.
How are the exosomes stored and what is their delivery method?
They are stored in liquid form at 2°C-8°C to maintain stability and are delivered via injection for precise application in treatments.
What clinical applications does this exosome therapy support?
It is used for cartilage repair in conditions like rhinitis, osteoarthritis, and joint injuries, helping to reduce inflammation, stimulate matrix synthesis, and improve mobility.